DK2615179T3 - Hidtil ukendt biologisk påvisningsfremgangsmåde til dioxiner i serum, og en diagnostisk anvendelse derfor i metabolisk syndrom og beslægtede tilstande - Google Patents

Hidtil ukendt biologisk påvisningsfremgangsmåde til dioxiner i serum, og en diagnostisk anvendelse derfor i metabolisk syndrom og beslægtede tilstande

Info

Publication number
DK2615179T3
DK2615179T3 DK11823757.7T DK11823757T DK2615179T3 DK 2615179 T3 DK2615179 T3 DK 2615179T3 DK 11823757 T DK11823757 T DK 11823757T DK 2615179 T3 DK2615179 T3 DK 2615179T3
Authority
DK
Denmark
Prior art keywords
dioxines
serum
metabolic syndrome
related conditions
determination procedure
Prior art date
Application number
DK11823757.7T
Other languages
English (en)
Inventor
Hong Kyu Lee
Youngmi Kim
Original Assignee
Univ-Industry Cooperation Group Of Kyung Hee Univ
Hong Kyu Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ-Industry Cooperation Group Of Kyung Hee Univ, Hong Kyu Lee filed Critical Univ-Industry Cooperation Group Of Kyung Hee Univ
Application granted granted Critical
Publication of DK2615179T3 publication Critical patent/DK2615179T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067Liver cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C12N2015/8527Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic for producing animal models, e.g. for tests or diseases
    • C12N2015/8572Animal models for proliferative diseases, e.g. comprising an oncogene
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK11823757.7T 2010-09-10 2011-09-06 Hidtil ukendt biologisk påvisningsfremgangsmåde til dioxiner i serum, og en diagnostisk anvendelse derfor i metabolisk syndrom og beslægtede tilstande DK2615179T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100088905A KR101272315B1 (ko) 2010-09-10 2010-09-10 새로운 혈청 내 다이옥신류의 생물학적 검출 방법, 및 이의 대사증후군 및 관련 증상에 대한 진단적 유용성
PCT/KR2011/006583 WO2012033324A2 (ko) 2010-09-10 2011-09-06 새로운 혈청 내 다이옥신류의 생물학적 검출 방법, 및 이의 대사증후군 및 관련 증상에 대한 진단적 유용성

Publications (1)

Publication Number Publication Date
DK2615179T3 true DK2615179T3 (da) 2017-11-13

Family

ID=45811063

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11823757.7T DK2615179T3 (da) 2010-09-10 2011-09-06 Hidtil ukendt biologisk påvisningsfremgangsmåde til dioxiner i serum, og en diagnostisk anvendelse derfor i metabolisk syndrom og beslægtede tilstande

Country Status (9)

Country Link
US (3) US20130171655A1 (da)
EP (1) EP2615179B1 (da)
JP (1) JP5736458B2 (da)
KR (1) KR101272315B1 (da)
CN (1) CN103270172B (da)
DK (1) DK2615179T3 (da)
HR (1) HRP20171436T1 (da)
SI (1) SI2615179T1 (da)
WO (1) WO2012033324A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101272315B1 (ko) 2010-09-10 2013-06-07 경희대학교 산학협력단 새로운 혈청 내 다이옥신류의 생물학적 검출 방법, 및 이의 대사증후군 및 관련 증상에 대한 진단적 유용성
CN109306001A (zh) * 2018-11-21 2019-02-05 浙江海洋大学 芳香烃受体核转位蛋白arnt——一种新型海洋生物污染检测标志物
CN109813913B (zh) * 2019-01-31 2021-11-09 中国医学科学院肿瘤医院 芳烃受体(AhR)在预测免疫治疗效果中的应用
CN114459859B (zh) * 2022-02-16 2022-09-09 北京卢米斯生物科技有限公司 基于荧光素酶报告基因法的高通量二噁英自动检测装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854010A (en) * 1997-03-10 1998-12-29 Denison; Michael S. Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor
US6432692B1 (en) * 1999-06-21 2002-08-13 Wisconsin Alumni Research Foundation Sensitive bioassay for detecting agonists of the aryl hydrocarbon receptor
KR100355301B1 (ko) * 1999-11-16 2002-10-12 학교법인 포항공과대학교 다이옥신류에 의하여 발현이 조절되는 재조합 리포터유전자를 가지는 형질전환 세포주를 이용한 다이옥신류의생물학적 분석방법
EP1767622B1 (en) * 2004-05-24 2011-03-02 University of Yamanashi Transgenic cell for assay of dioxin and utilizing the same, dioxin detecting method and biosensor
JP2006254714A (ja) * 2005-03-15 2006-09-28 Sumitomo Chemical Co Ltd Ahレセプター転写促進能増強細胞及びその利用
WO2007004361A1 (ja) 2005-07-01 2007-01-11 Yamanashi University 遺伝子導入非ヒト哺乳動物、およびこれを用いた環境中有害化学物質のモニタリング方法
KR101272315B1 (ko) 2010-09-10 2013-06-07 경희대학교 산학협력단 새로운 혈청 내 다이옥신류의 생물학적 검출 방법, 및 이의 대사증후군 및 관련 증상에 대한 진단적 유용성

Also Published As

Publication number Publication date
JP2013540433A (ja) 2013-11-07
JP5736458B2 (ja) 2015-06-17
CN103270172B (zh) 2016-03-16
EP2615179A4 (en) 2014-03-19
US20130171655A1 (en) 2013-07-04
WO2012033324A2 (ko) 2012-03-15
KR101272315B1 (ko) 2013-06-07
KR20120026788A (ko) 2012-03-20
SI2615179T1 (sl) 2017-12-29
US20170107584A1 (en) 2017-04-20
US20190309376A1 (en) 2019-10-10
EP2615179A2 (en) 2013-07-17
WO2012033324A3 (ko) 2012-06-14
US10697027B2 (en) 2020-06-30
EP2615179B1 (en) 2017-08-02
CN103270172A (zh) 2013-08-28
HRP20171436T1 (hr) 2017-11-03

Similar Documents

Publication Publication Date Title
DK2600800T3 (da) Indretning til lægemiddellevering i en ureterstent og kit dertil
DK2599877T3 (da) Hidtil ukendt pcr sekvenseringsfremgangsmåde og anvendelse deraf i hla-genotypebestemmelse
BRPI1016004A2 (pt) métodos para testar analitos e dispositivo para calcular a terapia de insulina basal.
BR112012014421A2 (pt) dispositivo para medir resposta de coagulação em uma amostra de sangue e método de medição de resposta de coagulação em uma amostra de sangue
DK2567240T4 (da) Lipidomiske biomarkører til aterosklerose og kardiovaskulær sygdom
DK3567363T3 (da) Prøvningsindretninger, -fremgangsmåder og reagenser
DK3067064T3 (da) Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf
DK2661329T3 (da) Forbedringer ved eller i forbindelse med en indretning til generering af ultralyd, og fremgangsmåder til generering af ultralyd
DK2683442T3 (da) Indretning til selektivt at påvirke og/eller dræbe bakterier
IT1397120B1 (it) Dispositivo integrato per analisi diagnostiche, e relativo procedimento
DK3831283T3 (da) Analytsensorindretninger, forbindelser og fremgangsmåder
BRPI1007593A2 (pt) aparelho para detectar e medir o álcool etílico na corrente sanguínea
DK2560972T3 (da) Forbindelser og fremgangsmåder til kinasemodulering og indikationer hertil
DK2405963T3 (da) Apparat, system og fremgangsmåde til at måle modstand i en inhalator
DK2265793T3 (da) Undervandstestapparat, konstruktionsenhed og fremgangsmåde
BR112012011646A2 (pt) sistema de teste de aptidão fisica e produto de programa de computador
DK2502065T3 (da) Indretning og fremgangsmåde til at analysere prøver for at diagnosticere sygdom
BR112012005568A2 (pt) aparelho e métodos para medir processos biológicos
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
BRPI0912210A2 (pt) dispositivo para medição e gerenciamento de analito e métodos associados
EP2724668A4 (en) DEVICE FOR THE ANALYSIS OF PSYCHICAL DISEASES, METHOD FOR THE ANALYSIS OF PSYCHICAL DISEASES AND PROGRAM THEREFOR
EP2660606A4 (en) BLOOD SUGAR MEASURING DEVICE
BR112013019162A2 (pt) método de análise e dispositivo de leitura de microarranjo
HK1172397A1 (en) Measuring system and measuring method, in particular for determining blood glucose
DK2410922T3 (da) Apparat til udførelse af diagnostiske og/eller terapeutiske procedurer